Insider · CIK 0001993292
Mitchell Lawrence Jones
officer
Files at PALI (PALISADE BIO, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | PALI PALISADE BIO, INC. | MOption exercise Common Stock | +2,620,850 | - | - | 2,714,859 | 5 d ago |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | FTax withholding Common Stock | -1,031,102 | $1.49 | $1.5M | 1,683,757 | 5 d ago |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | MOption exercise Restricted Stock Unitsderivative | -2,555,266 | $0.00 | $0 | 5,110,534 | 5 d ago |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | MOption exercise Restricted Stock Unitsderivative | -65,584 | $0.00 | $0 | 590,249 | 5 d ago |
| Feb 11, 2025 | PALI PALISADE BIO, INC. | AGrant or award Stock Option (Right to Buy)derivative | +29,000 | $0.00 | $0 | 29,000 | Feb 13, 2025 |
| Feb 11, 2025 | PALI PALISADE BIO, INC. | AGrant or award Restricted Stock Unitsderivative | +24,000 | $0.00 | $0 | 24,000 | Feb 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.